News

Ambit Biosciences (Ambit) and Astellas Pharma (Astellas) have entered into a worldwide agreement to jointly develop and commercialise FLT3 kinase inhibitors in oncology and non-oncology indications. The partnership

Teva UK (Teva) has launched generic co-Beneldopa capsules in a variety of strengths. The company said that they are the first generic to reach the market. Co-Beneldopa is

Freeman Technology’s FT4 universal powder tester is being used by a team of Australian scientist. The technology is used to develop methods for improving the flow properties of

National Institutes of Health (NIH) has presented data from the clinical trial on Revlimid. Initial results from a large, randomised clinical trial for patients with multiple myeloma, showed

CoxHealth has selected Omnicell as its primary vendor for automated medication management and supply solutions. CoxHealth will be using a variety of Omnicell solutions, including its automated medication

Global Med Technologies (Global Med) has reported that its Inlog, subsidiary has licensed its EdgeLab Laboratory Information Management Software to the centuries-old Centre Hospitalier de Verdun in Verdun,

WaveMark CIMS (WaveMark) has been awarded a contract by Phoenix Health Care Management Services/VHA Georgia (Phoenix Health Care) as a solution for its member hospitals and hospital networks

Scynexis has achieved a third milestone in its collaboration with Merck & Co to develop antifungal agents. The latest milestone payment was triggered following the initiation of clinical

The FDA has cleared Agendia’s MammaPrint breast cancer recurrence test for all ages. MammaPrint is the FDA-cleared breast cancer recurrence test available to patients and physicians. Over the